Search

Christine J. Saoud

Examiner (ID: 16605, Phone: (571)272-0891 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1645, 1812, 2899, 1616, 1647, 1646, 1801
Total Applications
1551
Issued Applications
753
Pending Applications
184
Abandoned Applications
635

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7691241 [patent_doc_number] => 20070232792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Method for the Production of Recombinant Peptides with a Low Amount of Trisulfides' [patent_app_type] => utility [patent_app_number] => 11/750692 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2123 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232792.pdf [firstpage_image] =>[orig_patent_app_number] => 11750692 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/750692
Method for the Production of Recombinant Peptides with a Low Amount of Trisulfides May 17, 2007 Abandoned
Array ( [id] => 5465672 [patent_doc_number] => 20090325872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'USE OF ALPHA-LACTALBUMIN FOR REGULATIONS OF GLYCEMIA' [patent_app_type] => utility [patent_app_number] => 12/298417 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5824 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325872.pdf [firstpage_image] =>[orig_patent_app_number] => 12298417 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/298417
Use of alpha-lactalbumin for regulations of glycemia Apr 23, 2007 Issued
Array ( [id] => 5465660 [patent_doc_number] => 20090325860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'COMPOSITIONS FOR INTRANASAL DELIVERY OF HUMAN INSULIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/376205 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 43035 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325860.pdf [firstpage_image] =>[orig_patent_app_number] => 12376205 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/376205
COMPOSITIONS FOR INTRANASAL DELIVERY OF HUMAN INSULIN AND USES THEREOF Apr 18, 2007 Abandoned
Array ( [id] => 162885 [patent_doc_number] => 07671180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Fibroblast growth factor-like polypeptides and variants thereof' [patent_app_type] => utility [patent_app_number] => 11/733769 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30292 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671180.pdf [firstpage_image] =>[orig_patent_app_number] => 11733769 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/733769
Fibroblast growth factor-like polypeptides and variants thereof Apr 10, 2007 Issued
Array ( [id] => 168859 [patent_doc_number] => 07667008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Fibroblast growth factor-like polypeptides and variants thereof' [patent_app_type] => utility [patent_app_number] => 11/733771 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30292 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667008.pdf [firstpage_image] =>[orig_patent_app_number] => 11733771 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/733771
Fibroblast growth factor-like polypeptides and variants thereof Apr 10, 2007 Issued
Array ( [id] => 6636206 [patent_doc_number] => 20100035804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'POLYPEPTIDE ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/296180 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7277 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035804.pdf [firstpage_image] =>[orig_patent_app_number] => 12296180 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296180
POLYPEPTIDE ANTAGONIST Apr 4, 2007 Abandoned
Array ( [id] => 4909153 [patent_doc_number] => 20080019919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium' [patent_app_type] => utility [patent_app_number] => 11/728075 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4727 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019919.pdf [firstpage_image] =>[orig_patent_app_number] => 11728075 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/728075
Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium Mar 22, 2007 Issued
Array ( [id] => 5285390 [patent_doc_number] => 20090099065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Acylated Single Chain Insulin' [patent_app_type] => utility [patent_app_number] => 12/282788 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13656 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099065.pdf [firstpage_image] =>[orig_patent_app_number] => 12282788 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/282788
Acylated Single Chain Insulin Mar 11, 2007 Abandoned
Array ( [id] => 5453178 [patent_doc_number] => 20090069215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Acylated Single Chain Insulin' [patent_app_type] => utility [patent_app_number] => 12/282787 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13402 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069215.pdf [firstpage_image] =>[orig_patent_app_number] => 12282787 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/282787
Acylated Single Chain Insulin Mar 11, 2007 Abandoned
Array ( [id] => 5453179 [patent_doc_number] => 20090069216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof' [patent_app_type] => utility [patent_app_number] => 12/280183 [patent_app_country] => US [patent_app_date] => 2007-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10112 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069216.pdf [firstpage_image] =>[orig_patent_app_number] => 12280183 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/280183
Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof Feb 18, 2007 Abandoned
Array ( [id] => 8642625 [patent_doc_number] => 08367609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Methods of reducing skin damage and edema' [patent_app_type] => utility [patent_app_number] => 11/654776 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16487 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11654776 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/654776
Methods of reducing skin damage and edema Jan 17, 2007 Issued
Array ( [id] => 5552979 [patent_doc_number] => 20090286965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'MUTANT GROWTH FACTORS WITH ALTERED RECEPTOR SPECIFICITIES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/159854 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8603 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286965.pdf [firstpage_image] =>[orig_patent_app_number] => 12159854 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/159854
Isolated mutant protein of fibroblast growth factor 18 and pharmaceutical composition comprising the same Jan 8, 2007 Issued
Array ( [id] => 5367255 [patent_doc_number] => 20090304814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'FIBRILLATION RESISTANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/160187 [patent_app_country] => US [patent_app_date] => 2007-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6049 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304814.pdf [firstpage_image] =>[orig_patent_app_number] => 12160187 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160187
Fibrillation resistant proteins Jan 7, 2007 Issued
Array ( [id] => 4983592 [patent_doc_number] => 20070088151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/642816 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38604 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088151.pdf [firstpage_image] =>[orig_patent_app_number] => 11642816 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/642816
Secreted and transmembrane polypeptides and nucleic acids encoding the same Dec 18, 2006 Abandoned
Array ( [id] => 5135997 [patent_doc_number] => 20070077626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/611037 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38335 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077626.pdf [firstpage_image] =>[orig_patent_app_number] => 11611037 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/611037
POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME Dec 13, 2006 Abandoned
Array ( [id] => 5236030 [patent_doc_number] => 20070128186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Proliferative glomerulonephritis-related gene' [patent_app_type] => utility [patent_app_number] => 11/606133 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32596 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128186.pdf [firstpage_image] =>[orig_patent_app_number] => 11606133 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/606133
Proliferative glomerulonephritis-related gene Nov 29, 2006 Abandoned
Array ( [id] => 5343238 [patent_doc_number] => 20090181888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/085221 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8237 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181888.pdf [firstpage_image] =>[orig_patent_app_number] => 12085221 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085221
Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient Nov 20, 2006 Abandoned
Array ( [id] => 5368410 [patent_doc_number] => 20090305969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/085220 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7356 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305969.pdf [firstpage_image] =>[orig_patent_app_number] => 12085220 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085220
Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient Nov 20, 2006 Abandoned
Array ( [id] => 5253888 [patent_doc_number] => 20070135344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Novel growth factor and a genetic sequence encoding same' [patent_app_type] => utility [patent_app_number] => 11/602055 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 9373 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135344.pdf [firstpage_image] =>[orig_patent_app_number] => 11602055 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/602055
Novel growth factor and a genetic sequence encoding same Nov 19, 2006 Abandoned
Array ( [id] => 4970733 [patent_doc_number] => 20070110735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods for regulating angiogenesis and vascular integrity using trk receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/589659 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14199 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110735.pdf [firstpage_image] =>[orig_patent_app_number] => 11589659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/589659
Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands Oct 29, 2006 Issued
Menu